SITAGLIPTIN VERSUS PLACEBO IN THE TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE: A RANDOMIZED CONTROLLED TRIAL

被引:5
|
作者
Cui, J. Y. [1 ]
Philo, L. [2 ]
Nguyen, P. [1 ]
Hofflich, H. [3 ]
Hernandez, C. [1 ]
Bettencourt, R. [4 ]
Richards, L. [1 ]
Salotti, J. [1 ]
Bhatt, A. [1 ]
Hooker, J. [5 ]
Haufe, W. [5 ]
Hooker, C. [1 ]
Brenner, D. A. [6 ]
Sirlin, C. B. [5 ]
Loomba, R. [1 ,4 ,6 ,7 ]
机构
[1] UC San Diego Sch Med, Dept Med, NAFLD Res Ctr, La Jolla, CA USA
[2] Naval Med Ctr, San Diego, CA USA
[3] UC San Diego Sch Med, Div Gen Internal Med, La Jolla, CA USA
[4] UC San Diego Sch Med, Dept Family & Prevent Med, Div Epidemiol, La Jolla, CA USA
[5] UC San Diego Sch Med, Dept Radiol, Liver Imaging Grp, La Jolla, CA USA
[6] UC San Diego Sch Med, Dept Med, Div Gastroenterol, La Jolla, CA USA
[7] San Diego Integrated NAFLD Consortium, San Diego, CA USA
关键词
D O I
10.1016/S0168-8278(16)00137-9
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
PS112
引用
收藏
页码:S192 / S193
页数:2
相关论文
共 50 条
  • [1] Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial
    Cui, Jeffrey
    Philo, Len
    Nguyen, Phirum
    Hofflich, Heather
    Hernandez, Carolyn
    Bettencourt, Ricki
    Richards, Lisa
    Salotti, Joanie
    Bhatt, Archana
    Hooker, Jonathan
    Haufe, William
    Hooker, Catherine
    Brenner, David A.
    Sirlin, Claude B.
    Loomba, Rohit
    JOURNAL OF HEPATOLOGY, 2016, 65 (02) : 369 - 376
  • [2] Treatment of Non-alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo-controlled Trial
    Rahmani, Sepideh
    Asgary, Sedigheh
    Askari, Gholamreza
    Keshvari, Mahtab
    Hatamipour, Mahdi
    Feizi, Awat
    Sahebkar, Amirhossein
    PHYTOTHERAPY RESEARCH, 2016, 30 (09) : 1540 - 1548
  • [3] Sitagliptin Versus Placebo in the Treatment of Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial
    Cui, Jeffrey Y.
    Philo, Len
    Phirum Nguyen
    Hofflich, Heather
    Hernandez, Carolyn
    Bettencourt, Ricki
    Richards, Lisa
    Salotti, Joanie
    Bhatt, Archana
    Hooker, Jonathan
    Haufe, William
    Hooker, Catherine A.
    Brenner, David A.
    Sirlin, Claude B.
    Loomba, Rohit
    GASTROENTEROLOGY, 2016, 150 (04) : S1055 - S1055
  • [4] Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial
    Saadati, Saeede
    Sadeghi, Amir
    Mansour, Asieh
    Yari, Zahra
    Poustchi, Hossein
    Hedayati, Mehdi
    Hatami, Behzad
    Hekmatdoost, Azita
    BMC GASTROENTEROLOGY, 2019, 19 (1)
  • [5] Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial
    Saeede Saadati
    Amir Sadeghi
    Asieh Mansour
    Zahra Yari
    Hossein Poustchi
    Mehdi Hedayati
    Behzad Hatami
    Azita Hekmatdoost
    BMC Gastroenterology, 19
  • [6] EFFICACY OF EZETIMIBE FOR THE TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE: A RANDOMIZED, CONTROLLED TRIAL
    Takeshita, Y.
    Takamura, T.
    Kita, Y.
    Misu, H.
    Arai, K.
    Yamashita, T.
    Mizukoshi, E.
    Kaneko, S.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S346 - S346
  • [7] Sitagliptin in patients with non-alcoholic steatohepatitis: A randomized, placebo-controlled trial
    Joy, Tisha R.
    McKenzie, Charles A.
    Tirona, Rommel G.
    Summers, Kelly
    Seney, Shannon
    Chakrabarti, Subrata
    Malhotra, Neel
    Beaton, Melanie D.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (01) : 141 - 150
  • [8] SITAGLIPTIN IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS: A RANDOMIZED, PLACEBO-CONTROLLED TRIAL
    Beaton, Melanie D.
    Joy, Tisha R.
    Tirona, Rommel G.
    Summers, Kelly
    Malhotra, Neel
    Chakrabarti, Subrata
    GASTROENTEROLOGY, 2017, 152 (05) : S1201 - S1201
  • [9] Sitagliptin in patients with non-alcoholic steatohepatitis: A randomized, placebo-controlled trial
    Tisha R Joy
    Charles A McKenzie
    Rommel G Tirona
    Kelly Summers
    Shannon Seney
    Subrata Chakrabarti
    Neel Malhotra
    Melanie D Beaton
    World Journal of Gastroenterology, 2017, (01) : 141 - 150
  • [10] Vitamin D supplementation for the treatment of non-alcoholic fatty liver disease: A randomized double blind placebo controlled trial
    Dabbaghmanesh, Mohammad Hossein
    Danafar, Farideh
    Eshraghian, Ahad
    Omrani, Gholamhossein Ranjbar
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2018, 12 (04) : 513 - 517